Clinical Trial Update: Phase 1 Study of Oral TP-1454 [Phase 1]

View source ↗

Summary

Phase 1 study of oral TP-1454 for advanced solid tumors and anal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer

Drugs mentioned

• TP-1454

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Advanced Solid Tumor, Anal Cancer | Phase 1 | Status: COMPLETED